✦ LIBER ✦

TCT-24 Late Outcomes of Unprotected Left Main Stenting in Comparison With Surgical Revascularization - Ten-Year Clinical Follow up of the LEMANS trial

✍ Scribed by Pawel, Buszman E.; Buszman, Piotr P.; Banasiewicz Szkrobka, Iwona; Milewski, Krzysztof P.; Zurakowski, Aleksander; Orlik, Bartłomiej; Wojakowski, Wojciech; Janas, Adam; Kiesz, R. Stefan; Bochenek, Andrzej

Book ID: 123323171
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 213 KB
Volume: 62
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2013.08.753

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acute and Late Outcomes of Unprotected L

Acute and Late Outcomes of Unprotected Left Main Stenting in Comparison With Surgical Revascularization

✍ Pawel E. Buszman; Stefan R. Kiesz; Andrzej Bochenek; Ewa Peszek-Przybyla; Iwona 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 579 KB

TCT-105: Three-year Follow-up Of The Syn

TCT-105: Three-year Follow-up Of The Syntax Trial: Optimal Revascularization Strategy In Patients With Left Main Disease

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 180 KB

TCT-49: Four-year Follow-up of the SYNTA

TCT-49: Four-year Follow-up of the SYNTAX Trial: Optimal Revascularization Strategy in Patients with Left Main Disease

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Long-Term Clinical Outcomes of Sirolimus

Long-Term Clinical Outcomes of Sirolimus- Versus Paclitaxel-Eluting Stents for Patients With Unprotected Left Main Coronary Artery Disease: Analysis of the MAIN-COMPARE (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) Registry

✍ Jong-Young Lee; Duk-Woo Park; Sung-Cheol Yun; Seung-Whan Lee; Young-Hak Kim; Che 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 375 KB

TCT-228: Four-year Follow-up of the SYNT

TCT-228: Four-year Follow-up of the SYNTAX Trial: Optimal Revascularization Strategy in Patients with Three-vessel Disease and/or Left Main Disease

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 261 KB

Improved Late Clinical Safety With Zotar

Improved Late Clinical Safety With Zotarolimus-Eluting Stents Compared With Paclitaxel-Eluting Stents in Patients With De Novo Coronary Lesions: 3-Year Follow-Up From the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) Trial

✍ Martin B. Leon; Eugenia Nikolsky; Donald E. Cutlip; Laura Mauri; Henry Liberman; 📂 Article 📅 2010 🏛 American College of Cardiology 🌐 English ⚖ 557 KB